Robin Couch is a research scientist who is investigating the development of new therapeutics for the treatment of Alzheimer’s disease. Couch is currently evaluating the effectiveness of neuroprotection, which involves the use of neurotrophins, or molecules naturally produced by resident cells in the brain, to defend the brain cells from death. This includes nerve growth factor which is a specific neurotrophin that binds to brain cells and promotes their survival. His other research interests include isoprene biosynthesis, personalized medicine and anti-cholesterol therapeutics.